Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.

Merger strengthens ophthalmic portfolio and accelerates commercialization COLUMBUS, Ohio, Aug. 19, 2024 /PRNewswire/ — Visiox Pharmaceuticals, Inc. announced today that it has entered into a definitive merger agreement with Ocuvex Therapeutics, Inc. a privately held ophthalmic…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.